학술논문
1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Document Type
Abstract
Author
Reijers, I.; Dimitriadis, P.; Menzies, A.M.; Kapiteijn, E.; Van der Veldt, A.A.M.; Suijkerbuijk, K.P.M.; Hospers, G.A.P.; Van Houdt, W.; Saw, R.; Broeks, A.; Cornelissen, S.; Grijpink-Ongering, L.; Pennington, T.; Colebatch, A.; van de Wiel, B.; Scolyer, R.; van Akkooi, A.C.J.; Long, G.V.; Blank, C.U.
Source
In Annals of Oncology October 2023 34 Supplement 2:S660-S660
Subject
Language
ISSN
0923-7534